Eloxx Pharmaceuticals Inc (NASDAQ:ELOX)

19.28
Delayed Data
As of 4:00pm ET
 +0.47 / +2.50%
Today’s Change
3.62
Today|||52-Week Range
24.60
+141.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash6.1M3.3M810.8K24.2M
 
 
 
 
 
Short Term Investment Cash4.5M-2.8M-2.5M21.8M
 
 
 
 
 
Cash & Short Term Investments6.1M3.3M810.8K24.2M
 
 
 
 
 
 
ReceivablesReceivables43.1K0.000.000.00
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses1.1M----267.0K
 
 
 
Other Current Assets0.00395.1K171.8K88.0K
 
 
 
 
Current Assets7.2M3.7M982.6K24.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross337.2K349.4K349.4K332.0K
 
 
 
 
 
Depreciation-113.7K-163.4K-256.8K-54.0K
 
 
 
 
 
Intangible Assets25.9M15.6M8.1M0.00
 
 
 
 
Other Assets25.9M15.6M8.1M0.00
 
 
 
 
Total Assets33.3M19.5M9.2M24.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable0.000.000.001.5M
 
 
Accrued Expenses794.6K266.9K172.6K1.5M
 
 
 
 
 
Other Current Liabilities1.7M636.7K285.2K1.5M
 
 
 
 
 
Other Liabilities1.8M778.5K369.0K3.4M
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-3.9M-3.9M-3.2M--
 
 
 
 
Other Liabilities99.7K2.6M1.1M0.00
 
 
 
 
Total Liabilities5.8M7.3M4.7M3.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock6.002.4K2.4K0.00
 
 
 
 
Common Equity27.5M12.2M4.6M21.4M
 
 
 
 
 
Total Shareholder Equity27.5M12.2M4.6M21.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding692.3K937.6K1.0M27.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.